S. N. Booth

472 total citations
12 papers, 363 citations indexed

About

S. N. Booth is a scholar working on Radiology, Nuclear Medicine and Imaging, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, S. N. Booth has authored 12 papers receiving a total of 363 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Radiology, Nuclear Medicine and Imaging, 4 papers in Surgery and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in S. N. Booth's work include Monoclonal and Polyclonal Antibodies Research (3 papers), Lung Cancer Research Studies (3 papers) and Gastroesophageal reflux and treatments (2 papers). S. N. Booth is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (3 papers), Lung Cancer Research Studies (3 papers) and Gastroesophageal reflux and treatments (2 papers). S. N. Booth collaborates with scholars based in United Kingdom, Ireland and Australia. S. N. Booth's co-authors include P W Dykes, J. C. Leonard, A.R. Bradwell, Simon F. Crowe, P. D. I. RICHARDSON, C M Bate, Michael D. Taylor, K R Hine, Z Drolc and P. W. N. Keeling and has published in prestigious journals such as The Lancet, Gut and Journal of Clinical Pathology.

In The Last Decade

S. N. Booth

12 papers receiving 322 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
S. N. Booth United Kingdom	9	153	128	112	109	75	12	363
R. Doerr United States	9	107 0.7×	120 0.9×	10 0.1×	100 0.9×	95 1.3×	15	317
D Jackson United States	9	264 1.7×	197 1.5×	69 0.6×	15 0.1×	307 4.1×	12	502
Kazuya Sonoda Japan	7	126 0.8×	109 0.9×	122 1.1×	44 0.4×	225 3.0×	14	353
Iain Paterson United Kingdom	9	231 1.5×	120 0.9×	29 0.3×	16 0.1×	165 2.2×	14	359
Ester Lörinc Sweden	9	306 2.0×	258 2.0×	79 0.7×	19 0.2×	91 1.2×	11	453
Makiko Hiratsuka Japan	10	238 1.6×	292 2.3×	20 0.2×	55 0.5×	128 1.7×	23	399
Yutaka Asakuma Japan	8	152 1.0×	97 0.8×	83 0.7×	13 0.1×	155 2.1×	18	279
Mariëtte C.A. van Kouwen Netherlands	10	106 0.7×	208 1.6×	35 0.3×	52 0.5×	120 1.6×	20	333
Xun Hou China	13	74 0.5×	67 0.5×	38 0.3×	45 0.4×	87 1.2×	34	298

Countries citing papers authored by S. N. Booth

Since Specialization

Citations

This map shows the geographic impact of S. N. Booth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. N. Booth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. N. Booth more than expected).

Fields of papers citing papers by S. N. Booth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. N. Booth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. N. Booth. The network helps show where S. N. Booth may publish in the future.

Co-authorship network of co-authors of S. N. Booth

This figure shows the co-authorship network connecting the top 25 collaborators of S. N. Booth. A scholar is included among the top collaborators of S. N. Booth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. N. Booth. S. N. Booth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Bate, C M, S. N. Booth, Simon F. Crowe, et al.. (1995). Omeprazole 10 mg or 20 mg once daily in the prevention of recurrence of reflux oesophagitis. Solo Investigator Group.. Gut. 36(4). 492–498. 75 indexed citations

Bate, C M, et al.. (1993). Does 40 mg omeprazole daily offer additional benefit over 20 mg daily in patients requiring more than 4 weeks of treatment for symptomatic reflux oesophagitis?. Alimentary Pharmacology & Therapeutics. 7(5). 501–507. 32 indexed citations

Booth, S. N., et al.. (1989). Single night‐time doses of 40 mg famotidine or 800 mg cimetidine in the treatment of duodenal ulcer. Alimentary Pharmacology & Therapeutics. 3(5). 505–512. 2 indexed citations

Dykes, P W, et al.. (1980). Localisation of tumour deposits by external scanning after injection of radiolabelled anti-carcinoembryonic antigen.. BMJ. 280(6209). 220–222. 70 indexed citations

Hine, K R, et al.. (1978). CARCINOEMBRYONIC ANTIGEN CONCENTRATIONS IN UNDIAGNOSED PATIENTS. The Lancet. 312(8104). 1337–1340. 14 indexed citations

Booth, S. N., Gregory E. Lakin, P W Dykes, David Burnett, & A.R. Bradwell. (1977). Cancer-associated proteins in effusion fluids.. Journal of Clinical Pathology. 30(6). 537–540. 29 indexed citations

Burnett, David, S. N. Booth, D.H. Cove, et al.. (1977). PREGNANCY-ASSOCIATED α2-GLYCOPROTEIN. The Lancet. 309(8005). 257–258. 5 indexed citations

Northam, B.E., et al.. (1974). The effect of serum protein concentrations on the specificity of the radioimmunoassay of carcinoembryonic antigen in malignant neoplasia and non-neoplastic disease. Journal of Clinical Pathology. 27(2). 130–134. 8 indexed citations

Booth, S. N., et al.. (1974). Carcinoembryonic Antigen in Management of Colorectal Carcinoma. BMJ. 4(5938). 183–187. 38 indexed citations

10.

Booth, S. N., et al.. (1974). The Significance of Elevation of Serum Carcinoembryonic Antigen (CEA) Levels in Inflammatory Diseases of the Intestine. Scandinavian Journal of Gastroenterology. 9(7). 651–656. 14 indexed citations

11.

Booth, S. N., et al.. (1973). Serum carcinoembryonic antigen in clinical disorders. Gut. 14(10). 794–799. 75 indexed citations

12.

Booth, S. N., et al.. (1973). Serum CEA in normal individuals and in clinical disorders.. PubMed. 124(4). 631–2. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact